Analytical Tool - Peptides in Oncology

  • ID: 1196680
  • March 2014
  • Region: Global
  • Bioseeker
1 of 2

"Analytical Tool- Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in peptide drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.
Included in this advantageous package are two products already appreciated by many of our customers:

Cancer Peptides: From First-in-Class to Best-in-Class?
Peptides in Oncology Drug Pipeline Update 2014*

The Package Includes
A progress analysis on current and emerging drugs
Information on most companies active in peptide drug development in READ MORE >

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. Online access is provided for this product. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • Photocure ASA
  • Roche Diagnostics Ltd.
  • Abbott Laboratories Ltd.
  • Pfizer, Inc.
  • Novartis AG
  • Becton, Dickinson and Company (BD)